Key result
Low-frequency magnetic fields boost chemotherapy-induced breast cancer cell kill without stimulating cell growth.
Why the study?
Non-ionizing electromagnetic radiation, particularly magnetic fields, has been implicated in human neoplasia development and may influence cancer progression or treatment.
Does a low-frequency magnetic field affect the growth of breast carcinoma cells or improve cell kill when combined with chemotherapy?
Does a low-frequency magnetic field affect the growth of breast carcinoma cells or improve cell kill when combined with chemotherapy?
Low-frequency magnetic fields may enhance the efficacy of antineoplastic chemotherapy in breast carcinoma cells in vitro without stimulating cancer cell growth on their own.
NIEMR may promote progression of established breast cancer cells; leaves open relevance to human detection or outcomes.
Non-ionizing electromagnetic radiation (NIEMR), particularly the magnetic field component, has been implicated in the development of human neoplasia. Research suggests that if these fields are part of the carcinogenic pathway, they may act as a promoter or in the progression of established cancer. Active progression of cancer cells by NIEMR negate the possible early detection of clinically silent neoplasms. We have observed the effect of non-ionizing electromagnetic fields on an established breast carcinoma cell line MCF-7, and found no stimulation of growth when exposed to a low-frequency magnetic field. The same magnetic field has been used as an adjuvant to anti-neoplastic chemotherapeutic agents. The results of this study have shown an improvement in the neoplastic cell kill by antineoplastic chemotherapy when coupled with a low frequency magnetic field. Non-ionizing electromagnetic radiation may be involved in the carcinogenic process; however, the answer to this question awaits further studies. We are exploring new methods of cancer treatment using non-ionizing electromagnetic radiation.
No takes yet. Share an insight, caveat, or question.
Salvatore et al. (1994) studied Breast carcinoma (MCF-7 cell line). Low-frequency magnetic field vs. Antineoplastic chemotherapy alone was evaluated on Cell growth and neoplastic cell kill. A low-frequency magnetic field did not stimulate growth of the MCF-7 breast carcinoma cell line and improved neoplastic cell kill when used as an adjuvant to antineoplastic chemotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: